Zecotek Medical Systems Inc.
TSX VENTURE : ZMS
FRANKFURT : W1I

Zecotek Medical Systems Inc.

November 09, 2007 03:15 ET

Zecotek's Advanced Dye Laser Selected by Gwangju Institute of Science and Technology, Korea

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 9, 2007) - Zecotek Medical Systems Inc. (TSX VENTURE:ZMS)(FRANKFURT:W1I) today announced the sale of a CW single-frequency ring Dye laser system to Korea's prestigious Gwangju Institute of Science and Technology (GIST) for high-precision laser spectroscopy in its Advanced Photonics Research Institute. GIST was established in 1993 by the Republic of Korea to meet the nation's needs for advanced research and to take a leading role in performing research and development with industry sectors.

"We are very pleased that Korea's prestigious Gwangju Institute of Science and Technology has selected our CW Dye laser for their advanced spectroscopy program, following a highly competitive international selection process," said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. "This is an excellent endorsement of both the technical superiority and cost effectiveness of our new lines of laser products."

Zecotek's frequency-stabilized CW single-frequency ring Dye laser, model DYE-SF-077, is a further development of model DYE-SF-07 which includes a new system of frequency stabilization based on a thermo-stabilized interferometer and a fast electronic driver. This model provides a line width of less than 100 kHz, setting a new standard for commercial dye lasers, where previously the narrowest available line-width was 500 kHz - 1 MHz.

About Gwangju Institute of Science and Technology

The Gwangju Institute of Science and Technology is a research-oriented graduate school established by the Ministry of Science and Technology in the Republic of Korea in 1993. For more information visit: http://www.gist.ac.kr/english.

About Zecotek

Zecotek Medical Systems (TSX VENTURE:ZMS)(FRANKFURT:W1I) is a photonics technology company developing high-performance crystals, photo detectors, lasers, optical imaging and 3D display technologies for commercial applications in the medical diagnostics and high-tech industry. Founded in 2003, the company has three distinct operating divisions: imaging, lasers and 3D display and labs located in Canada, Singapore and Russia. Zecotek commercializes its novel, patented and patent-pending photonic technologies directly and through strategic alliances and joint ventures with multinational OEMs, distributors and other industry leaders. For more information, please visit www.zecotek.com.

This press release may contain forward-looking statements that are based on management's expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.

If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

Contact Information

  • Zecotek Medical Systems Inc.
    Michael Minder
    CFO; VP Corporate Development
    (604) 827-5203
    or
    Caliber Capital Partners
    Tim McNulty
    (778) 327-6678
    Email: ir@zecotek.com
    Website: www.zecotek.com